Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 6/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 8/20 | 0.41 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.41 |
| ▸ | GCGR | P47871 | 1/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 3/20 | 0.40 |
| ▸ | TEK | Q02763 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6835859 | 0.86 | NPY5R (0.69) | NPY5RNPC1RAB9AMAPK14CYP19A1 | |
| SCHEMBL6835195 | 0.85 | NPY5R (0.48) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL6834673 | 0.85 | NPY5R (0.67) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL6835180 | 0.84 | NPY5R (0.69) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL6836970 | 0.82 | NPY5R (0.64) | NPY5RMAPK14MAPK13GCGRMAPK12 | |
| SCHEMBL6835219 | 0.81 | NPY5R (0.68) | NPY5RNPC1RAB9AKDM4EKMT2A | |
| SCHEMBL6835211 | 0.73 | NPY5R (0.66) | NPY5RNPC1RAB9AMAPK14MAPK13 | |
| SCHEMBL6835192 | 0.72 | NPY5R (0.50) | NPY5RCYP19A1CYP11B2TYMS | |
| SCHEMBL6835188 | 0.72 | NPY5R (0.61) | NPY5RNPC1RAB9AMAPK14MAPK13 | |
| SCHEMBL6836929 | 0.71 | NPY5R (0.69) | NPY5RNPC1RAB9ACYP11B2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040198791-A1 | Fused imidazole derivative | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198791-A1 | Fused imidazole derivative | H1-0, H1-5, H1-3 | NPY5R 983/4885NPC1 1784/4885RAB9A 2021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.